The Efficacy and Safety of Ciprofol Versus Propofol in Patients Undergoing Painless Hysteroscopy: a Randomized, Double-blind, Controlled Trial

Overview

Journal BMC Anesthesiol

Publisher Biomed Central

Specialty Anesthesiology

Date 2024 Nov 12

PMID 39533194

Authors

Aijun Li

Ning Li

Lei Zhu

Zige Xu

Yifan Wang

Junjie Li

Gerong Zhang

Affiliations

Soon will be listed here.

Abstract

Background: Studies have reported that ciprofol has the advantage of reducing injection pain compared to propofol during gastroscopy, colonoscopy, and fiberoptic bronchoscopy. The effect of ciprofol on the injection pain in painless hysteroscopy needs to further explore.

Methods: A double-blind randomized controlled trial (RCT) was designed, and patients were recruited from the First Central Hospital of Baoding from March 2024 to June 2024. The eligible participants were allocated into ciprofol group (ciprofol combined with alfentanil) and propofol group (propofol combined with alfentanil) at 1:1 ratio. The primary outcome was injection pain. The secondary outcomes included sedation success rate, anesthesia success rate, adverse events, patient satisfaction, and comparison of vital signs before and after administration.

Results: A total of 217 participants were included for analysis, with 109 participants in the ciprofol group and 108 participants in the propofol group. The injection pain rate of ciprofol group (18.35%) was significantly lower than the propofol group (40.74%). Both the ciprofol group and propofol group had 100% of the sedation success rate. The anesthesia success rate between the two groups was comparable (P > 0.05). The rate of adverse events was lower (27.52% vs. 45.37%) and patient satisfaction was higher (9.84 ± 0.45 vs. 9.65 ± 0.85) in the ciprofol group than the propofol group. In addition, values of systolic blood pressure (SBP), diastolic blood pressure (DBP), and mean arterial pressure (MAP) in propofol group were significantly lower than those in ciprofol group at the time of cervical dilation and consciousness recovery.

Conclusions: Ciprofol exhibits comparable efficacy to that of propofol, and is associated with less injection pain rate, fewer adverse events, higher patient satisfaction, and more stable hemodynamics when used for general anesthesia during the painless hysteroscopy.

Clinical Trial Number: NCT06413862.

References

Desousa K . Pain on propofol injection: Causes and remedies. Indian J Pharmacol. 2017; 48(6):617-623. PMC: 5155459. DOI: 10.4103/0253-7613.194845. View

Glowacki D . Effective pain management and improvements in patients' outcomes and satisfaction. Crit Care Nurse. 2015; 35(3):33-41. DOI: 10.4037/ccn2015440. View

Chen X, Guo P, Yang L, Liu Z, Yu D . Comparison and Clinical Value of Ciprofol and Propofol in Intraoperative Adverse Reactions, Operation, Resuscitation, and Satisfaction of Patients under Painless Gastroenteroscopy Anesthesia. Contrast Media Mol Imaging. 2022; 2022:9541060. PMC: 9314164. DOI: 10.1155/2022/9541060. View

Li X, Yang D, Li Q, Wang H, Wang M, Yan P . Safety, Pharmacokinetics, and Pharmacodynamics of a Single Bolus of the γ-aminobutyric Acid (GABA) Receptor Potentiator HSK3486 in Healthy Chinese Elderly and Non-elderly. Front Pharmacol. 2021; 12:735700. PMC: 8430033. DOI: 10.3389/fphar.2021.735700. View

Qiu Q, Choi S, Wong S, Irwin M, Cheung C . Effects of intra-operative maintenance of general anaesthesia with propofol on postoperative pain outcomes - a systematic review and meta-analysis. Anaesthesia. 2016; 71(10):1222-33. DOI: 10.1111/anae.13578. View

Sahinovic M, Struys M, Absalom A . Clinical Pharmacokinetics and Pharmacodynamics of Propofol. Clin Pharmacokinet. 2018; 57(12):1539-1558. PMC: 6267518. DOI: 10.1007/s40262-018-0672-3. View

Liao J, Li M, Huang C, Yu Y, Chen Y, Gan J . Pharmacodynamics and Pharmacokinetics of HSK3486, a Novel 2,6-Disubstituted Phenol Derivative as a General Anesthetic. Front Pharmacol. 2022; 13:830791. PMC: 8851058. DOI: 10.3389/fphar.2022.830791. View

De Silva P, Mahmud A, Smith P, Clark T . Analgesia for Office Hysteroscopy: A Systematic Review and Meta-analysis. J Minim Invasive Gynecol. 2020; 27(5):1034-1047. DOI: 10.1016/j.jmig.2020.01.008. View

Yu J, Xiang B, Song Y, Chen H, Li Y, Liu C . ED50 of propofol in combination with low-dose sufentanil for intravenous anaesthesia in hysteroscopy. Basic Clin Pharmacol Toxicol. 2019; 125(5):460-465. DOI: 10.1111/bcpt.13280. View

10.

Wikstrom L, Nilsson M, Brostrom A, Eriksson K . Patients' self-reported nausea: Validation of the Numerical Rating Scale and of a daily summary of repeated Numerical Rating Scale scores. J Clin Nurs. 2018; 28(5-6):959-968. DOI: 10.1111/jocn.14705. View

11.

Qin L, Ren L, Wan S, Liu G, Luo X, Liu Z . Design, Synthesis, and Evaluation of Novel 2,6-Disubstituted Phenol Derivatives as General Anesthetics. J Med Chem. 2017; 60(9):3606-3617. DOI: 10.1021/acs.jmedchem.7b00254. View

12.

Chen B, Yin X, Jiang L, Liu J, Shi Y, Yuan B . The efficacy and safety of ciprofol use for the induction of general anesthesia in patients undergoing gynecological surgery: a prospective randomized controlled study. BMC Anesthesiol. 2022; 22(1):245. PMC: 9347095. DOI: 10.1186/s12871-022-01782-7. View

13.

Fischer M, Leffler A, Niedermirtl F, Kistner K, Eberhardt M, Reeh P . The general anesthetic propofol excites nociceptors by activating TRPV1 and TRPA1 rather than GABAA receptors. J Biol Chem. 2010; 285(45):34781-92. PMC: 2966094. DOI: 10.1074/jbc.M110.143958. View

14.

Zhang X, Li S, Liu J . Efficacy and safety of remimazolam besylate versus propofol during hysteroscopy: single-centre randomized controlled trial. BMC Anesthesiol. 2021; 21(1):156. PMC: 8135983. DOI: 10.1186/s12871-021-01373-y. View

15.

Wang X, Liu J, Zuo Y, Zhu Q, Wei X, Zou X . Effects of ciprofol for the induction of general anesthesia in patients scheduled for elective surgery compared to propofol: a phase 3, multicenter, randomized, double-blind, comparative study. Eur Rev Med Pharmacol Sci. 2022; 26(5):1607-1617. DOI: 10.26355/eurrev_202203_28228. View

16.

Wu B, Zhu W, Wang Q, Ren C, Wang L, Xie G . Efficacy and safety of ciprofol-remifentanil versus propofol-remifentanil during fiberoptic bronchoscopy: A prospective, randomized, double-blind, non-inferiority trial. Front Pharmacol. 2023; 13:1091579. PMC: 9812563. DOI: 10.3389/fphar.2022.1091579. View

17.

Salazar C, Isaacson K . Office Operative Hysteroscopy: An Update. J Minim Invasive Gynecol. 2017; 25(2):199-208. DOI: 10.1016/j.jmig.2017.08.009. View

18.

Paulo A, Solheiro M, Paulo C, Afreixo V . What proportion of women refers moderate to severe pain during office hysteroscopy with a mini-hysteroscope? A systematic review and meta-analysis. Arch Gynecol Obstet. 2015; 293(1):37-46. DOI: 10.1007/s00404-015-3836-5. View

19.

Wu X, Wang C, Gao H, Bai X, Zhang Z, Chen R . Comparison of remimazolam and propofol about safety outcome indicators during general anesthesia in surgical patients: a systematic review and meta-analysis. Minerva Anestesiol. 2023; 89(6):553-564. DOI: 10.23736/S0375-9393.23.17034-9. View

20.

Lan H, Shan W, Wu Y, Xu Q, Dong X, Mei P . Efficacy and Safety of Ciprofol for Sedation/Anesthesia in Patients Undergoing Hysteroscopy: A Randomized, Parallel-Group, Controlled Trial. Drug Des Devel Ther. 2023; 17:1707-1717. PMC: 10272418. DOI: 10.2147/DDDT.S414243. View